Evaluation of therapeutic effect of low dose naltrexone in experimentally-induced Crohn's disease in rats
- 1 October 2016
- journal article
- Published by Elsevier in Neuropeptides
- Vol. 59, 39-45
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn’s Disease: A Randomized Placebo-Controlled TrialDigestive Diseases and Sciences, 2011
- Aminosalicylates for induction of remission or response in Crohn's disease2010
- Opioid receptors in the gastrointestinal tractRegulatory Peptides, 2009
- Low-dose naltrexone for disease prevention and quality of lifeMedical Hypotheses, 2009
- Afferent nerve sensitivity is decreased by an iNOS‐dependent mechanism during indomethacin‐induced inflammation in the murine jejunum in vitroNeurogastroenterology & Motility, 2009
- Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseaseGastrointestinal Endoscopy, 2006
- Indomethacin‐induced ileitis is associated with tensiometric, vascular and oxidative changes in the experimental rat modelEuropean Journal of Clinical Investigation, 2005
- Antagonists, Inverse Agonists, and ProtagonistsJournal of Clinical Psychopharmacology, 2003
- Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis ratsGut, 1998
- Alcohol induces formation of morphine precursors in the striatum of ratsLife Sciences, 1996